AI assistant
Siemens AG — Interim / Quarterly Report 2021
May 10, 2021
390_10-q_2021-05-10_7c34cdc5-daae-4214-8cf8-d9bb18d08a02.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
Half-year Financial Report
FIRST HALF OF FISCAL 2021

Table of contents
| 3 | A | Interim Group Management Report |
|---|---|---|
| 3 | A.1 | Results of operations |
| 5 | A.2 | Net assets and financial position |
| 6 | A.3 | Outlook |
| 6 | A.4 | Risks and opportunities |
| 7 | B | Half-year Consolidated Financial Statements |
| 7 | B.1 | Consolidated Statements of Income |
| 7 | B.2 | Consolidated Statements of Comprehensive Income |
| 8 | B.3 | Consolidated Statements of Financial Position |
| 9 | B.4 | Consolidated Statements of Cash Flows |
| 10 | B.5 | Consolidated Statements of Changes in Equity |
| 11 | B.6 | Notes to Half-year Consolidated Financial Statements |
| 16 | C | Additional information |
| 16 | C.1 | Responsibility statement |
| 16 | C.2 | Review report |
| 17 | C.3 | Notes and forward-looking statements |
Introduction
Siemens AG's Half-year Financial Report complies with the applicable legal requirements of the German Securities Trading Act (Wertpapierhandelsgesetz – WpHG) and comprises condensed Half-year Consolidated Financial Statements, an Interim Group Management Report and a Responsibility statement in accordance with section 115 WpHG.
The Half-year Consolidated Financial Statements are in accordance with IFRS applicable to interim financial reporting as issued by the IASB and as adopted by the EU.
This Half-year Financial Report should be read in conjunction with our Annual Report for fiscal 2020, which includes a detailed analysis of our operations and activities as well as explanations of financial measures used.
A. Interim Group Management Report
In the first half of fiscal 2021, Siemens sold 100% of its shares in Flender GmbH including Siemens' Wind Energy Generation business (Flender). The results of Flender are reported within discontinued operations. Prior-period amounts are presented on a comparable basis. For more detailed information, please refer to Note 2 in B.6 Notes to Half-year Consolidated Financial Statements.
A.1 Results of operations
- Continuing complex macroeconomic environment influenced by the coronavirus pandemic (COVID-19)
- Pent-up demand and growth opportunities varied by business and geographic region
A.1.1 Orders and revenue by regions
| Location of customer | Orders | Revenue | ||||||
|---|---|---|---|---|---|---|---|---|
| First half | % Change | First half | % Change | |||||
| (in millions of €) | FY 2021 | FY 2020 | Actual | Comp. | FY 2021 | FY 2020 | Actual | Comp. |
| Europe, C.I.S., Africa, Middle East | 16,908 | 14,443 | 17% | 17% | 14,553 | 13,675 | 6% | 7% |
| therein: Germany | 6,193 | 4,965 | 25% | 21% | 5,157 | 4,643 | 11% | 8% |
| Americas | 7,319 | 7,948 | (8)% | 2% | 7,275 | 7,637 | (5)% | 5% |
| therein: U.S. | 6,046 | 6,518 | (7)% | 2% | 6,035 | 6,371 | (5)% | 4% |
| Asia, Australia | 7,593 | 6,634 | 14% | 18% | 6,907 | 6,148 | 12% | 15% |
| therein: China | 4,274 | 3,453 | 24% | 26% | 3,827 | 2,962 | 29% | 31% |
| Siemens (continuing operations) | 31,819 | 29,024 | 10% | 13% | 28,736 | 27,459 | 5% | 8% |
| therein: emerging markets | 8,921 | 7,738 | 15% | 22% | 8,173 | 7,473 | 9% | 16% |
Orders
- On a worldwide basis, order intake up clearly year-over-year on increases in all four industrial businesses, led by substantial growth in Mobility, due primarily to a higher volume from large orders, and by a significant increase in Siemens Healthineers
- Substantial negative currency translation effects took five percentage points from order growth year-over-year, while portfolio transactions added one percentage point
- Strong book-to-bill ratio of 1.11; order backlog at €72 billion, up from €69 billion as of September 30, 2020
- Europe, C.I.S. Africa, Middle East: Order intake up in all four industrial businesses, led by sharp growth in Siemens Healthineers and a significant increase in Mobility which recorded a sharply higher volume from large orders year-over-year; order growth was even stronger in Germany, which largely followed the pattern for the region
- Americas: Decline both in the region and in the U.S. on a nominal basis due to substantial negative currency translation effects; on a comparable basis, excluding currency translation and portfolio effects, order growth in Mobility and Smart Infrastructure more than offset declines in Siemens Healthineers and Digital Industries
- Asia, Australia: Growth in all four industrial businesses, led by Digital Industries and Siemens Healthineers; order growth was even stronger in China where all four industrial businesses recorded double-digit growth
Revenue
- On a worldwide basis, revenue up in all four industrial businesses, led by clear growth in Siemens Healthineers and Digital Industries
- Substantial negative currency translation effects took five percentage points from revenue growth year-over-year, while portfolio transactions added one percentage point
- Europe, C.I.S. Africa, Middle East: Revenue grew across all four industrial businesses, led by a substantial increase in Siemens Healthineers; even stronger growth in Germany included a sharp revenue increase in Siemens Healthineers
- Americas: As with orders, revenue decreased on a nominal basis due to substantial negative currency translation effects; on a comparable basis, double-digit increases in Mobility and Digital Industries; revenue development in the U.S. largely followed the pattern for the region
- Asia, Australia: Significant growth in the region, led by a strong performance of Digital Industries in China; double-digit increases in Siemens Healthineers and Smart Infrastructure
| Profit (IB, POC: Adj. EBITA; SFS: EBT) |
Profit margin (Adj. EBITA margin; SFS: ROE) |
|||||
|---|---|---|---|---|---|---|
| First half | First half | |||||
| (in millions of €, earnings per share in €) | FY 2021 | FY 2020 | % Change | FY 2021 | FY 2020 | |
| Digital Industries | 1,659 | 1,126 | 47% | 21.3% | 15.1% | |
| Smart Infrastructure | 781 | 466 | 68% | 11.1% | 6.6% | |
| Mobility | 427 | 428 | 0% | 9.6% | 9.6% | |
| Siemens Healthineers | 1,349 | 1,104 | 22% | 17.2% | 15.2% | |
| Industrial Businesses (IB) | 4,216 | 3,124 | 35% | 15.5% | 11.9% | |
| Siemens Financial Services (SFS) | 272 | 305 | (11)% | 17.0% | 20.2% | |
| Portfolio Companies (POC) | (71) | (54) | (33)% | (5.2)% | (3.2)% | |
| Reconciliation to Consolidated Financial Statements | (469) | (632) | 26% | |||
| Income from continuing operations before income taxes | 3,948 | 2,744 | 44% | |||
| Income tax expenses | (957) | (564) | (70)% | |||
| Income from continuing operations | 2,991 | 2,179 | 37% | |||
| Income (loss) from discontinued operations, net of income taxes | 897 | (394) | n/a | |||
| Net income | 3,888 | 1,786 | 118% | |||
| Basic earnings per share | 4.55 | 2.13 | 113% | |||
| ROCE | 17.1% | 6.4% |
Industrial Businesses
- Digital Industries: Adjusted EBITA higher in all businesses, with the strongest increases in the electronic design automation (EDA) software and short-cycle businesses; key factors included higher revenue, expense reductions due to COVID-19 restrictions, such as lower travel and marketing expenses, cost savings from prior cost structure improvements, and substantially lower severance charges year-over-year
- Smart Infrastructure: Adjusted EBITA and profitability rose in all businesses, due largely to sharply lower severance charges, higher capacity utilization, cost savings resulting from prior execution of the competitiveness program, and expense reductions related to COVID-19 restrictions
- Mobility: Adjusted EBITA and profitability on the strong prior-year level despite ongoing impacts due to COVID-19-related measures to safeguard employee health in manufacturing facilities
- Siemens Healthineers: Margin expansion and increase in Adjusted EBITA in the diagnostics business mainly driven by high demand for rapid coronavirus antigen tests; continuing strong performance of the imaging business
- Severance charges for Industrial Businesses were €166 million (H1 FY 2020: €330 million)
Income from continuing operations before income taxes
- SFS: Results in the equity business came in below the level of H1 FY 2020 in part due to sales of investments in previous periods; strong earnings contribution from the debt business driven by sharply lower expenses for credit risk provisions compared to H1 FY 2020, when results were significantly influenced by the initial worldwide spread of COVID-19
- Portfolio Companies: Adjusted EBITA included sharply higher severance charges related to cost structure improvements mainly at Large Drives Applications, which more than offset a decreased burden recorded for equity investments
- Reconciliation to Financial Statements in both periods included gains in connection with the transfer of assets to Siemens Pension-Trust e.V., totaling €0.4 billion in H1 FY 2021, compared to €0.2 billion in the same period a year earlier
- Severance charges for continuing operations were €267 million (H1 FY 2020: €378 million)
Income from continuing operations
Tax rate of 24.2% benefited from largely tax-free gains resulting from the transfers of assets to Siemens Pension-Trust e.V. mentioned above
Income (loss) from discontinued operations, net of income taxes
Discontinued operations turned positive due primarily to a pre-tax gain of €0.9 billion from the sale of Flender; in the prior-year period, loss in Siemens' former energy business
Net income, Basic earnings per share, ROCE
- Basic earnings per share more than doubled year-over-year due to sharply higher income attributable to shareholders of Siemens AG
- ROCE higher and within the target range on a combination of sharply higher net income and a substantial decrease in average capital employed following the spin-off of Siemens Energy AG; increase benefited from the above-mentioned gain from the sale of Flender
A.2 Net assets and financial position
Asset and capital structure
| Mar 31, | Sep 30, | ||
|---|---|---|---|
| (in millions of €) | 2021 | 2020 | % Change |
| Current assets | 63,793 | 52,968 | 20% |
| therein: Cash and cash equivalents |
23,639 | 14,041 | 68% |
| Non-current assets | 67,865 | 70,928 | (4)% |
| therein: Other financial assets | 20,175 | 22,771 | (11)% |
| Total assets | 131,658 | 123,897 | 6% |
| Debt | 52,098 | 44,567 | 17% |
| Provisions for pensions and similar obligations |
3,288 | 6,360 | (48)% |
| Other liabilities | 31,676 | 33,147 | (4)% |
| Equity | 44,595 | 39,823 | 12% |
| Total liabilities and equity | 131,658 | 123,897 | 6% |
| Cash flows | ||||||
|---|---|---|---|---|---|---|
| First half FY 2021 | ||||||
| (in millions of €) | Continuing operations |
Discontinued operations |
Continuing and discontinued operations |
|||
| Cash flows from: | ||||||
| Operating activities | 2,924 | (19) | 2,905 | |||
| Investing activities | (899) | 1,522 | 623 | |||
| therein: Additions to intangible assets and property, plant and equipment |
(692) | (26) | (719) | |||
| Free cash flow | 2,232 | (45) | 2,187 | |||
| Financing activities | 5,954 | − | 5,955 |
- Three of our four industrial businesses posted cash inflows from operating activities within continuing operations, with the strongest conversion of Adjusted EBITA into cash by Siemens Healthineers; Mobility reported an aggregate cash outflow driven by a build-up of operating net working capital; this was also the largest factor for overall cash outflows from the change in net working capital, which totaled €0.9 billion
- Cash inflows from investing activities from discontinued operations were driven by the sale of Flender, which resulted in cash inflows (net of cash disposed) of €1.6 billion in the current period, with €0.2 billion in proceeds to follow mainly at the beginning of the second half of fiscal 2021; for information on the derecognition of assets and liabilities relating to the sale please refer to Note 2 in B.6 Notes to Half-year Consolidated Financial Statements
- The decrease of other financial assets was due mainly to the repayment and reclassification of loans receivable to other current financial assets, and to extraordinary fundings to Siemens Pension-Trust e.V. in Germany. The latter was also the main factor for the decrease of provisions for pensions and similar obligations, together with a positive return on plan assets; weighted-average discount rate as of March 31, 2021: 1.2% (September 30, 2020: 1.1%); for further information please refer to Note 6 in B.6 Notes to Half-year Consolidated Financial Statements
- Debt increased primarily from the issuance of bonds and new bank loans. This increase was partly offset by repayment of debt including a reduction of commercial paper. Further cash inflows from financing activities related to Siemens Healthineers AG's issuance of 53 million new shares. This issuance resulted also in a corresponding increase of equity. For further information please refer to Notes 2 and 3 in B.6 Notes to Half-year Consolidated Financial Statements
- At the beginning of the second half of fiscal 2021, Siemens paid the purchase price of €13.9 billion for Varian Medical Systems, Inc., U.S. in cash; for further information on this acquisition please refer to Note 2 in B.6 Notes to Half-year Consolidated Financial Statements
A.3 Outlook
Although we continue to anticipate a complex macroeconomic environment influenced by COVID-19, we expect our businesses to continue to deliver a strong performance in the second half of fiscal 2021. Furthermore, we realized substantial gains from portfolio transactions in the first half of the fiscal year. Therefore, we raise our outlook for the fiscal year.
We continue to anticipate that negative currency effects will strongly burden both nominal growth rates in volume and Adjusted EBITA for our industrial businesses in fiscal 2021.
We now raise our expectation for comparable revenue, net of currency translation and portfolio effects, to growth of 9% to 11%. We continue to expect a book-to-bill ratio above 1.
In line with the results already achieved during the first half of fiscal 2021 and the expectations described above, we raise our outlook for net income to the range from €5.7 to €6.2 billion.
As previously, this outlook excludes burdens from legal and regulatory issues and effects in connection with Siemens Healthineers' acquisition of Varian Medical Systems, Inc.
A.4 Risks and opportunities
During the reporting period, we identified no further significant risks and opportunities besides those presented in our Annual Report for fiscal 2020 and in this Half-year Financial Report. Additional risks and opportunities not known to us or that we currently consider immaterial could also affect our business operations. At present, no risks have been identified that either individually or in combination with other risks could endanger our ability to continue as a going concern.
B. Half-year Consolidated Financial Statements
B.1 Consolidated Statements of Income
| First half | ||
|---|---|---|
| (in millions of €, per share amounts in €) Note |
FY 2021 | FY 2020 |
| Revenue | 28,736 | 27,459 |
| Cost of sales | (18,177) | (17,459) |
| Gross profit | 10,558 | 10,000 |
| Research and development expenses | (2,192) | (2,283) |
| Selling and general administrative expenses | (5,021) | (5,489) |
| Other operating income | 149 | 329 |
| Other operating expenses | (282) | (163) |
| Income (loss) from investments accounted for using the equity method, net | (70) | 42 |
| Interest income | 707 | 831 |
| Interest expenses | (330) | (454) |
| Other financial income (expenses), net | 429 | (69) |
| Income from continuing operations before income taxes | 3,948 | 2,744 |
| Income tax expenses | (957) | (564) |
| Income from continuing operations | 2,991 | 2,179 |
| Income (loss) from discontinued operations, net of income taxes 2 |
897 | (394) |
| Net income | 3,888 | 1,786 |
| Attributable to: | ||
| Non-controlling interests | 246 | 52 |
| Shareholders of Siemens AG | 3,642 | 1,734 |
| Basic earnings per share | ||
| Income from continuing operations | 3.43 | 2.52 |
| Income (loss) from discontinued operations | 1.12 | (0.39) |
| Net income | 4.55 | 2.13 |
| Diluted earnings per share | ||
| Income from continuing operations | 3.39 | 2.49 |
| Income (loss) from discontinued operations | 1.11 | (0.38) |
| Net income | 4.49 | 2.11 |
B.2 Consolidated Statements of Comprehensive Income
| First half | ||
|---|---|---|
| (in millions of €) | FY 2021 | FY 2020 |
| Net income | 3,888 | 1,786 |
| Remeasurements of defined benefit plans | 1,224 | 363 |
| therein: Income tax effects | (56) | (416) |
| Remeasurements of equity instruments | 16 | 17 |
| therein: Income tax effects | − | (3) |
| Income (loss) from investments accounted for using the equity method, net | 44 | (4) |
| Items that will not be reclassified to profit or loss | 1,285 | 376 |
| Currency translation differences Derivative financial instruments |
612 (170) |
(1,100) (18) |
| therein: Income tax effects | 53 | − |
| Income (loss) from investments accounted for using the equity method, net Items that may be reclassified subsequently to profit or loss |
19 462 |
(33) (1,152) |
| Other comprehensive income, net of income taxes | 1,746 | (776) |
| Total comprehensive income | 5,633 | 1,010 |
| Attributable to: | ||
| Non-controlling interests | 197 | 10 |
| Shareholders of Siemens AG | 5,437 | 1,000 |
B.3 Consolidated Statements of Financial Position
| Mar 31, | Sep 30, | |
|---|---|---|
| (in millions of €) Note |
2021 | 2020 |
| Assets | ||
| Cash and cash equivalents | 23,639 | 14,041 |
| Trade and other receivables | 13,951 | 14,074 |
| Other current financial assets | 9,144 | 8,382 |
| Contract assets | 5,963 | 5,545 |
| Inventories | 7,956 | 7,795 |
| Current income tax assets | 1,601 | 1,523 |
| Other current assets | 1,299 | 1,271 |
| Assets classified as held for disposal 2 |
241 | 338 |
| Total current assets | 63,793 | 52,968 |
| Goodwill | 20,605 | 20,449 |
| Other intangible assets | 4,664 | 4,838 |
| Property, plant and equipment | 10,089 | 10,250 |
| Investments accounted for using the equity method | 7,847 | 7,862 |
| Other financial assets | 20,175 | 22,771 |
| Deferred tax assets | 2,828 | 2,988 |
| Other assets | 1,657 | 1,769 |
| Total non-current assets | 67,865 | 70,928 |
| Total assets | 131,658 | 123,897 |
| Liabilities and equity | ||
| Short-term debt and current maturities of long-term debt 3 |
8,528 | 6,562 |
| Trade payables | 7,274 | 7,873 |
| Other current financial liabilities | 1,757 | 1,958 |
| Contract liabilities | 7,882 | 7,524 |
| Current provisions | 1,611 | 1,674 |
| Current income tax liabilities | 1,628 | 2,281 |
| Other current liabilities | 5,937 | 6,209 |
| Liabilities associated with assets classified as held for disposal 2 |
11 | 35 |
| Total current liabilities | 34,629 | 34,117 |
| Long-term debt 3 |
43,570 | 38,005 |
| Provisions for pensions and similar obligations | 3,288 | 6,360 |
| Deferred tax liabilities | 677 | 664 |
| Provisions | 2,329 | 2,352 |
| Other financial liabilities | 738 | 769 |
| Other liabilities | 1,831 | 1,808 |
| Total non-current liabilities | 52,434 | 49,957 |
| Total liabilities | 87,063 | 84,074 |
| Equity 2, 4 |
||
| Issued capital | 2,550 | 2,550 |
| Capital reserve | 6,846 | 6,840 |
| Retained earnings | 36,291 | 33,078 |
| Other components of equity | (939) | (1,449) |
| Treasury shares, at cost | (4,622) | (4,629) |
| Total equity attributable to shareholders of Siemens AG | 40,126 | 36,390 |
| Non-controlling interests | 4,469 | 3,433 |
| Total equity | 44,595 | 39,823 |
| Total liabilities and equity | 131,658 | 123,897 |
| First half | ||
|---|---|---|
| (in millions of €) | FY 2021 | FY 2020 |
| Cash flows from operating activities | ||
| Net income | 3,888 | 1,786 |
| Adjustments to reconcile net income to cash flows from operating activities - continuing operations | ||
| (Income) loss from discontinued operations, net of income taxes | (897) | 394 |
| Amortization, depreciation and impairments | 1,406 | 1,466 |
| Income tax expenses | 957 | 564 |
| Interest (income) expenses, net | (377) | (377) |
| (Income) loss related to investing activities | (328) | (317) |
| Other non-cash (income) expenses | 192 | 528 |
| Change in operating net working capital from | ||
| Contract assets | (384) | (248) |
| Inventories | (472) | (902) |
| Trade and other receivables | (417) | 229 |
| Trade payables | (3) | (579) |
| Contract liabilities | 353 | 413 |
| Additions to assets leased to others in operating leases | (210) | (257) |
| Change in other assets and liabilities | (18) | (1,029) |
| Income taxes paid | (1,525) | (1,147) |
| Dividends received | 107 | 120 |
| Interest received | 654 | 720 |
| Cash flows from operating activities - continuing operations | 2,924 | 1,363 |
| Cash flows from operating activities - discontinued operations | (19) | (162) |
| Cash flows from operating activities - continuing and discontinued operations | 2,905 | 1,201 |
| Cash flows from investing activities | ||
| Additions to intangible assets and property, plant and equipment | (692) | (680) |
| Acquisitions of businesses, net of cash acquired | (225) | (1,657) |
| Purchase of investments and financial assets for investment purposes | (709) | (566) |
| Change in receivables from financing activities | 345 | (988) |
| Disposal of intangibles and property, plant and equipment | 50 | 40 |
| Disposal of businesses, net of cash disposed | 2 | (2) |
| Disposal of investments and financial assets for investment purposes | 331 | 678 |
| Cash flows from investing activities - continuing operations | (899) | (3,175) |
| Cash flows from investing activities - discontinued operations | 1,522 | (429) |
| Cash flows from investing activities - continuing and discontinued operations | 623 | (3,604) |
| Cash flows from financing activities | ||
| Purchase of treasury shares | (23) | (995) |
| Re-issuance of treasury shares and other transactions with owners | 2,154 | (96) |
| Issuance of long-term debt | 8,316 | 6,265 |
| Repayment of long-term debt (including current maturities of long-term debt) | (1,609) | (3,053) |
| Change in short-term debt and other financing activities | 483 | 2,636 |
| Interest paid | (327) | (456) |
| Dividends paid to shareholders of Siemens AG | (2,804) | (3,174) |
| Dividends attributable to non-controlling interests | (235) | (167) |
| Cash flows from financing activities - continuing operations | 5,954 | 960 |
| Cash flows from financing activities - discontinued operations | − | (928) |
| Cash flows from financing activities - continuing and discontinued operations | 5,955 | 32 |
| Effect of changes in exchange rates on cash and cash equivalents | 102 | (150) |
| Change in cash and cash equivalents | 9,585 | (2,521) |
| Cash and cash equivalents at beginning of period | 14,054 | 12,391 |
| Cash and cash equivalents at end of period Less: Cash and cash equivalents of assets classified as held for disposal and discontinued operations |
23,639 | 9,870 |
| at end of period | − | 2,038 |
| Cash and cash equivalents at end of period (Consolidated Statements of Financial Position) | 23,639 | 7,832 |
B.5 Consolidated Statements of Changes in Equity
| Issued capital |
Capital reserve |
Retained earnings |
Currency translation differences |
Equity instruments |
Derivative financial instruments |
Treasury shares at cost |
Total equity attributable to share holders of Siemens AG |
Non controlling interests |
Total equity |
|
|---|---|---|---|---|---|---|---|---|---|---|
| (in millions of €) | ||||||||||
| Balance as of October 1, 2019 | 2,550 | 6,839 | 41,790 | 1,409 | (49) | (226) | (3,663) | 48,650 | 2,858 | 51,508 |
| Net income | − | − | 1,734 | − | − | − | − | 1,734 | 52 | 1,786 |
| Other comprehensive income, net of income taxes | − | − | 355 | (1,081) | 17 | (25) | − | (734) | (42) | (776) |
| Dividends | − | − | (3,174) | − | − | − | − | (3,174) | (200) | (3,374) |
| Share-based payment | − | (12) | (95) | − | − | − | − | (106) | 5 | (101) |
| Purchase of treasury shares | − | − | − | − | − | − | (1,047) | (1,047) | − | (1,047) |
| Re-issuance of treasury shares | − | 5 | − | − | − | − | 449 | 454 | − | 454 |
| Disposal of equity instruments | − | − | (2) | − | − | − | − | (2) | − | (2) |
| Transactions with non-controlling interests | − | 1 | (1,136) | − | − | − | − | (1,135) | (88) | (1,223) |
| Other changes in equity | − | − | (11) | − | − | − | − | (11) | 1 | (11) |
| Balance as of March 31, 2020 | 2,550 | 6,834 | 39,460 | 328 | (32) | (251) | (4,261) | 44,627 | 2,587 | 47,214 |
| Balance as of October 1, 2020 | 2,550 | 6,840 | 33,078 | (1,292) | (42) | (115) | (4,629) | 36,390 | 3,433 | 39,823 |
| Net income | − | − | 3,642 | − | − | − | − | 3,642 | 246 | 3,888 |
| Other comprehensive income, net of income taxes | − | − | 1,284 | 608 | 17 | (115) | − | 1,795 | (49) | 1,746 |
| Dividends | − | − | (2,804) | − | − | − | − | (2,804) | (233) | (3,037) |
| Share-based payment | − | (27) | (60) | − | − | − | − | (87) | − | (87) |
| Purchase of treasury shares | − | − | − | − | − | − | (300) | (300) | − | (300) |
| Re-issuance of treasury shares | − | 33 | − | − | − | − | 307 | 340 | − | 340 |
| Changes in equity resulting from major portfolio transactions | − | − | 1,229 | − | − | − | − | 1,229 | 1,095 | 2,325 |
| Other transactions with non-controlling interests | − | − | (80) | − | − | − | − | (79) | (24) | (104) |
| Other changes in equity | − | − | 1 | − | − | − | − | 1 | 1 | 2 |
| Balance as of March 31, 2021 | 2,550 | 6,846 | 36,291 | (683) | (25) | (231) | (4,622) | 40,126 | 4,469 | 44,595 |
B.6 Notes to Half-year Consolidated Financial Statements
NOTE 1 Basis of presentation
The accompanying condensed Half-year Consolidated Financial Statements as of March 31, 2021 present the operations of Siemens AG and its subsidiaries (the Company or Siemens). These Half-year Consolidated Financial Statements are in accordance with IFRS applicable to interim financial reporting as issued by the IASB and as adopted by the EU and should be read in conjunction with the Siemens Consolidated Financial Statements as of September 30, 2020. The Half-year Consolidated Financial Statements apply the same accounting principles and practices as those used in the 2020 annual financial statements. Results for the interim reporting period are not necessarily indicative of future results. In interim periods, tax expense is based on the current estimated annual effective tax rate of Siemens. The presentation of certain prior year information is reclassified to conform to the current year presentation. The Half-year Consolidated Financial Statements are unaudited and were authorized for issue by the Managing Board on May 5, 2021. For further information on changes in estimates (including income taxes and pensions), disaggregation of revenue and on segment information (including Covid-19 impacts), see disclosures in the Interim Group Management Report. Due to rounding, numbers disclosed may not add up precisely to totals provided.
NOTE 2 Acquisitions, dispositions and discontinued operations
Subsequent event: Acquisition of Varian Medical Systems, Inc.
In April 2021, Siemens Healthineers acquired Varian Medical Systems, Inc., U.S. (Varian), which is a world leader in the field of cancer care, with innovative solutions especially in radiation oncology and related digital solutions and applications. Varian thus offers an ideal fit to Siemens Healthineers' leading businesses in medical imaging, laboratory diagnostics and interventional procedures. The purchase price paid in cash is €13.9 billion as of the acquisition date. Due to the proximity of the closing of the acquisition to the date this report was authorized for issue, the preparation of the purchase price allocation (including goodwill allocation to cash-generating units or groups of cash-generating units) is at a very early stage. It is expected that a major part of the purchase price will be allocated to Other intangible assets and Goodwill. Resulting Other intangible assets will mainly relate to technologies for Varian's oncology solutions. Goodwill will comprise intangible assets that are not separable such as employee know-how and expected synergy effects. Synergies from the acquisition are mainly expected from broader regional coverage of the sales network, cross-selling opportunities into existing customer base and from expanded integrated service offerings (e.g. Oncology-as-a-Service program), value partnerships, as well as joint product innovation. Besides, cost synergies, resulting from the merger of the two businesses, are expected in the administrative field and in procurement activities.
Dilution of the stake in Siemens Healthineers
In March 2021, Siemens Healthineers placed 53 million new shares to institutional investors, receiving gross proceeds of €2.3 billion and increasing its share capital to €1.128 billion. Siemens did not participate in the placement, thus, Siemens' stake in Siemens Healthineers decreased from 79% to 75%. The dilution is accounted for as equity transaction, which increased Non-controlling interests by €1.0 billion and Total equity attributable to shareholders of Siemens AG by €1.3 billion (mainly due to an increase in Retained earnings of €1.2 billion).
Discontinued operations: Sale of Flender GmbH
In October 2020, Siemens signed an agreement to sell 100% of its shares in Flender GmbH including Siemens' Wind Energy Generation business (Flender) to The Carlyle Group, U.S. Both businesses were previously reported under Portfolio Companies. In the first quarter of fiscal 2021, the businesses of Flender (the disposal group) met the criteria for classification as held for disposal as well as for discontinued operation, and, accordingly, Siemens ceased depreciation and amortization of assets within the disposal group.
Upon closing of the transaction on March 10, 2021, Siemens no longer controls Flender. The consideration was €1.875 billion. Derecognised net assets amounted to €954 million. Overall, in the six months ended March 31, 2021, Siemens recorded a disposal gain of €884 million.
The results of Flender are reported as discontinued operations in the Consolidated Statements of Income and Cash Flows for all periods presented:
| First half | ||
|---|---|---|
| (in millions of €) | FY 2021 | FY 2020 |
| Revenue | 928 | 877 |
| Expenses | (817) | (809) |
| Disposal gain | 884 | − |
| Income (loss) from discontinued operations before income taxes | 995 | 68 |
| Income taxes on ordinary activities | (23) | (15) |
| Other income taxes | (39) | − |
| Income (loss) from discontinued operations, net of income taxes | 932 | 53 |
| thereof attributable to Siemens AG shareholders | 932 | 53 |
The carrying amounts of the major classes of assets and liabilities derecognized were as follows:
| (in millions of €) | Mar 10, 2021 |
|---|---|
| Cash and cash equivalents | 95 |
| Trade and other receivables | 510 |
| Other current financial assets | 143 |
| Inventories | 540 |
| Goodwill | 123 |
| Property, plant and equipment | 359 |
| Miscellaneous current and non-current assets | 92 |
| Assets classified as held for disposal | 1,862 |
| Trade payables | 355 |
| Other current financial liabilities | 193 |
| Miscellaneous current liabilities | 244 |
| Miscellaneous non-current liabilities | 116 |
| Liabilities associated with assets classified as held for disposal | 907 |
NOTE 3 Debt
| Current debt | |||||||
|---|---|---|---|---|---|---|---|
| (in millions of €) | Mar 31, | Sep 30, | Mar 31, | Sep 30, | |||
| 2021 | 2020 | 2021 | 2020 | ||||
| Notes and bonds | 5,131 | 3,537 | 40,334 | 34,728 | |||
| Loans from banks | 1,235 | 321 | 1,045 | 1,076 | |||
| Other financial indebtedness | 1,478 | 2,021 | 59 | 55 | |||
| Lease liabilities | 685 | 683 | 2,132 | 2,146 | |||
| Total debt | 8,528 | 6,562 | 43,570 | 38,005 |
Credit facilities: In the six months ended March 31, 2021, the unused €7.0 billion syndicated credit facility maturing in 2025 was extended to mature in 2026 with no extension option remaining. The €3.0 billion unused syndicated credit facility matured in December 2020. The €12.5 billion unused syndicated bridge facility was cancelled by Siemens in March 2021.
Debt Issuance Program: In the six months ended March 31, 2021, Siemens' Debt Issuance Program was increased to €30.0 billion, thereof unused €7.9 billion as of March 31, 2021. The 1.75% €1.25 billion fixed-rate instrument was redeemed as due.
US\$ Bonds: In March 2021, Siemens issued instruments totaling US\$10.0 billion (€8.5 billion at March 31, 2021) in seven tranches: 0.4% US\$1.25 billion fixed-rate instrument due March 2023; Compounded SOFR+0.43% US\$1.0 billion floating-rate instrument due March 2024; 0.65% US\$1.5 billion fixed-rate instrument due March 2024; 1.2% US\$1.75 billion fixed-rate instrument due March 2026; 1.7% US\$1.25 billion fixed-rate instrument due March 2028; 2.15% US\$1.75 billion fixed-rate instrument due March 2031 and 2.875% US\$1.5 billion fixed-rate instrument due March 2041.
Assignable and term loans: In the six months ended March 31, 2021, three bilateral term loan facilities were newly signed: one bilateral €500 million term loan facility maturing in fiscal 2022 with a one one-year extension option; one bilateral US\$150 million term loan facility (€128 million) maturing in fiscal 2022 with a one one-year extension option and one bilateral US\$350 million term loan facility (€299 million) maturing in fiscal 2022 with a one one-year extension option.
Commercial Paper Program: As of March 31, 2021, and September 30, 2020, US\$1.6 billion (€1.4 billion) and US\$2.3 billion (€2.0 billion) in commercial paper were outstanding, respectively.
NOTE 4 Shareholders' equity
In the six months ended March 31, 2021 and 2020, Siemens repurchased 198 thousand and 13,520 thousand treasury shares, respectively. Siemens transferred 3,361 thousand and 4,556 thousand shares of treasury stock, respectively, in the six months ended March 31, 2021 and 2020. In the second quarter of fiscal 2021, a dividend of €3.50 per share was paid.
NOTE 5 Commitments and contingencies
The following table presents the undiscounted amount of maximum potential future payments for major groups of guarantees:
| Mar 31, | Sep 30, | |
|---|---|---|
| (in millions of €) | 2021 | 2020 |
| Credit guarantees | 537 | 604 |
| Performance guarantees | 21,711 | 27,917 |
| 22,248 | 28,521 |
As of March 31, 2021 and September 30, 2020, in addition to guarantees disclosed in the table above, there are contingent liabilities of €505 million and €405 million which mainly result from other guarantees, from joint and several liabilities of consortia, in particular from the construction of a power plant in Finland, as well as from indemnifications in connection with dispositions of businesses.
As of March 31, 2021 and September 30, 2020, Credit guarantees include €173 million and €271 million, performance guarantees
include €21,130 million and €27,425 million and other guarantees include €231 million and €261 million relating to the Siemens Energy business which were not transferred; however, for which Siemens holds reimbursement rights towards Siemens Energy.
NOTE 6 Financial instruments and hedging activities
Financial instruments measured at cost or amortized cost for which the carrying amount does not approximate fair value:
| Mar 31, 2021 | Sep 30, 2020 | |||
|---|---|---|---|---|
| Carrying | Carrying | |||
| (in millions of €) | Fair value | amount | Fair value | amount |
| Notes and bonds | 47,235 | 45,464 | 40,868 | 38,264 |
| Loans from banks and other financial indebtedness | 3,813 | 3,817 | 3,483 | 3,473 |
The following table allocates financial assets and liabilities measured at fair value to the three levels of the fair value hierarchy:
| Mar 31, 2021 | |||||||
|---|---|---|---|---|---|---|---|
| (in millions of €) | Level 1 | Level 2 | Level 3 | Total | |||
| Financial assets measured at fair value, thereof: | 457 | 2,376 | 665 | 3,498 | |||
| Equity instruments measured at fair value through profit and loss | 120 | 359 | 207 | 686 | |||
| Equity instruments measured at fair value through Other comprehensive income | 121 | 1 | 444 | 566 | |||
| Debt instruments measured at fair value through profit and loss | 216 | − | 15 | 231 | |||
| Derivative financial instruments | − | 2,015 | − | 2,015 | |||
| Financial liabilities measured at fair value – Derivative financial instruments | − | 909 | − | 909 |
In the six months ended March 31, 2021, Siemens Advanta acquired a 7.7% equity stake in a US software consultancy firm for €271 million in cash. The Level 2 financial asset is mandatorily measured at fair value through profit and loss (FVTPL). The fair value is determined based on observable market inputs that have not materially changed since the acquisition.
In the six months ended March 31, 2021, a Level 3 equity investment mandatorily measured at FVTPL was merged with a public holding company in exchange for shares in the new entity. The transaction resulted in a gain of €220 million derived from now available Level 1 quoted prices. The gain is disclosed in Other financial income (expenses), net and in Next47 of Corporate items. Subsequently, the investment was transferred to the Siemens Pension-Trust e.V. at fair value of €270 million.
Siemens transferred a zero-coupon receiver swap at fair value of €262 million to the Siemens Pension-Trust e.V. in the six months ended March 31, 2021. In November 2020, to fund its pension plan, Siemens transferred its stake in Bentley Systems, Inc., measured at FVTPL, to the Siemens Pension-Trust e.V. The contribution amounts to €1,146 million; Corporate items includes income of €192 million from the investment's fair value measurement before its transfer.
In the six months ended March 31, 2021, Siemens entered into foreign currency forward contracts to hedge foreign currency risks relating to the US\$10 billion (€8.5 billion) bonds achieving a synthetic Euro financing structure which factually, also turns interest into € with volume weighted average interest rates of currently about 0.3%. Foreign currency swaps of nominal US\$7.7 billion were designated to hedge foreign currency risks of the highly probable purchase price payment for Varian.
NOTE 7 Segment information
| Orders | External revenue | Intersegment Revenue |
Total revenue |
Profit | Assets | Free cash flow | Additions to Amortization, intangible depreciation & assets and impairments property, plant & equipment |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| First half | First half | First half | First half | First half | Mar 31, | Sep 30, | First half | First half | First half | |||||||||
| (in millions of €) | FY 2021 | FY 2020 | FY 2021 | FY 2020 | FY 2021 | FY 2020 | FY 2021 | FY 2020 | FY 2021 | FY 2020 | 2021 | 2020 | FY 2021 | FY 2020 | FY 2021 | FY 2020 | FY 2021 | FY 2020 |
| Digital Industries | 8,440 | 8,399 | 7,626 | 7,076 | 170 | 370 | 7,796 | 7,446 | 1,659 | 1,126 | 9,891 | 10,756 | 1,579 | 1,045 | 85 | 81 | 317 | 353 |
| Smart Infrastructure | 7,807 | 7,552 | 6,890 | 6,785 | 149 | 261 | 7,039 | 7,046 | 781 | 466 | 4,808 | 4,340 | 685 | 299 | 69 | 86 | 158 | 166 |
| Mobility | 4,869 | 4,049 | 4,449 | 4,425 | 16 | 18 | 4,465 | 4,443 | 427 | 428 | 3,185 | 3,424 | (107) | (80) | 76 | 69 | 92 | 138 |
| Siemens Healthineers | 8,878 | 7,941 | 7,807 | 7,225 | 27 | 47 | 7,833 | 7,272 | 1,349 | 1,104 | 15,272 | 15,338 | 1,454 | 626 | 285 | 242 | 407 | 391 |
| Industrial Businesses | 29,994 | 27,941 | 26,771 | 25,511 | 362 | 695 | 27,133 | 26,207 | 4,216 | 3,124 | 33,157 | 33,859 | 3,612 | 1,891 | 514 | 478 | 974 | 1,049 |
| Siemens Financial Services | 341 | 378 | 326 | 356 | 15 | 22 | 341 | 378 | 272 | 305 | 29,053 | 28,946 | 440 | 338 | 8 | 14 | 103 | 118 |
| Portfolio Companies | 1,624 | 1,637 | 1,288 | 1,405 | 84 | 292 | 1,372 | 1,697 | (71) | (54) | 711 | 767 | 102 | 43 | 9 | 12 | 26 | 30 |
| Reconciliation to Consolidated Financial Statements |
(140) | (932) | 350 | 187 | (461) | (1,010) | (111) | (823) | (469) | (632) | 68,737 | 60,325 | (1,923) | (1,589) | 162 | 175 | 302 | 269 |
| Siemens (continuing operations) | 31,819 | 29,024 | 28,736 | 27,459 | − | − | 28,736 | 27,459 | 3,948 | 2,744 | 131,658 | 123,897 | 2,232 | 683 | 692 | 680 | 1,406 | 1,466 |
Segment information is disclosed for continuing operations; prior year Assets are reclassified to conform to the current year presentation. Segment measurement principles are the same as those described in the September 30, 2020 Annual Report. Revenue includes revenue from contracts with customers and revenue from leasing activities. In the six months ended March 31, 2021 and 2020, lease revenue is €506 million and €465 million, respectively.
Reconciliation to Consolidated Financial Statements
Profit
| First half | ||||
|---|---|---|---|---|
| (in millions of €) | FY 2021 | FY 2020 | ||
| Siemens Energy Investment | (63) | − | ||
| Siemens Real Estate | 70 | 271 | ||
| Corporate items | (59) | (313) | ||
| Centrally carried pension expense | (95) | (111) | ||
| Amortization of intangible assets acquired in business combinations | (303) | (359) | ||
| Eliminations, Corporate Treasury and other reconciling items | (20) | (119) | ||
| Reconciliation to Consolidated Financial Statements | (469) | (632) |
Assets
| Mar 31, | Sep 30, | |
|---|---|---|
| (in millions of €) | 2021 | 2020 |
| Siemens Energy Investment | 6,765 | 6,748 |
| Assets Siemens Real Estate | 4,453 | 3,898 |
| Assets Corporate items and pensions | (204) | (608) |
| Asset-based adjustments: | ||
| Intragroup financing receivables | 62,544 | 51,431 |
| Tax-related assets | 4,319 | 4,335 |
| Liability-based adjustments | 27,992 | 27,568 |
| Eliminations, Corporate Treasury, other items | (37,132) | (33,049) |
| Reconciliation to Consolidated Financial Statements | 68,737 | 60,325 |
NOTE 8 Related party transactions
Siemens has relationships with many joint ventures and associates in the ordinary course of business whereby Siemens buys and sells a wide variety of products and services generally on arm's length terms. The transactions between continuing operations and joint ventures and associates were as follows:
| Sales of goods and services and other income |
Purchases of goods and services and other expenses |
Receivables | Liabilities | |||||
|---|---|---|---|---|---|---|---|---|
| First half | First half | Mar 31, | Sep 30, | Mar 31, | Sep 30, | |||
| (in millions of €) | FY 2021 | FY 2020 | FY 2021 | FY 2020 | 2021 | 2020 | 2021 | 2020 |
| Joint ventures | 77 | 76 | 4 | 21 | 86 | 76 | 25 | 49 |
| Associates | 537 | 39 | 278 | 45 | 1,115 | 1,105 | 924 | 1,358 |
| 613 | 115 | 283 | 66 | 1,202 | 1,181 | 949 | 1,407 |
In the first six months ended March 31, 2021 and 2020, sales of goods and services and other income resulting from transactions between discontinued operations and joint ventures and associates amounted to €97 million and €240 million, respectively. Purchases of goods and services and other expenses resulting from transactions between discontinued operations and joint ventures and associates amounted to €1 million and €84 million, respectively.
As of March 31, 2021 and September 30, 2020, guarantees to joint ventures and associates amounted to €20,854 million and €27,505 million, respectively, therein €20,613 million and €27,253 million, respectively, to associates. They included mainly Siemens' obligations from performance and credit guarantees in connection with the Siemens Energy business. For these guarantees, Siemens has reimbursement rights for the full amount.
As of March 31, 2021 and September 30, 2020, loans given to joint ventures and associates amounted to €997 million and €900 million, respectively, therein €979 million and €881 million related to joint ventures, respectively. The related book values amounted to €31 million and €26 million, therein €25 million and €20 million related to joint ventures, respectively. Valuation adjustments recognized in the first six months ended March 31, 2021 and March 31, 2020 reduced book values of loans related to joint ventures by €98 million and €153 million, respectively.
As of March 31, 2021 and September 30, 2020, the Company had commitments to make capital contributions of €75 million and €62 million to its joint ventures and associates, therein €65 million and €51 million related to joint ventures, respectively. As of March 31, 2021 and September 30, 2020, there were loan commitments to joint ventures amounting to €342 million and €299 million, respectively.
C. Additional information
C.1 Responsibility statement
To the best of our knowledge, and in accordance with the applicable reporting principles for half-year financial reporting, the Halfyear Consolidated Financial Statements give a true and fair view of the assets, liabilities, financial position and profit or loss of the Group, and the Interim Group Management Report includes a fair review of the development and performance of the business and the position of the Group, together with a description of the material opportunities and risks associated with the expected development of the Group for the remaining months of the financial year.
Munich, May 5, 2021
Siemens Aktiengesellschaft
The Managing Board
Dr. Roland Busch
| Cedrik Neike | Matthias Rebellius |
|---|---|
| Prof. Dr. Ralf P. Thomas | Judith Wiese |
C.2 Review Report
To Siemens Aktiengesellschaft, Berlin and Munich
We have reviewed the half-year consolidated financial statements comprising the consolidated statements of income, comprehensive income, financial position, cash flows and changes in equity, and notes to half-year consolidated financial statements, and the interim group management report, of Siemens Aktiengesellschaft, Berlin and Munich for the period from October 1, 2020 to March 31, 2021 which are part of the half-year financial report pursuant to Sec. 115 WpHG ("Wertpapierhandelsgesetz": German Securities Trading Act). The Company's management is responsible for the preparation of the half-year consolidated financial statements in accordance with IFRS applicable to interim financial reporting as issued by the IASB and as adopted by the EU and of the interim group management report in accordance with the requirements of the WpHG applicable to interim group management reports. Our responsibility is to issue a report on the half-year consolidated financial statements and the interim group management report based on our review.
We conducted our review of the half-year consolidated financial statements and the interim group management report in compliance with German Generally Accepted Standards for the Review of Financial Statements promulgated by the Institut der Wirtschaftsprüfer (IDW - Institute of Public Auditors in Germany) and in supplementary compliance with International Standard on Review Engagements 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity". Those standards require that we plan and perform the review to obtain a certain level of assurance in our critical appraisal to preclude that the half-year consolidated financial statements are not prepared, in all material respects, in accordance with IFRS applicable to interim financial reporting as issued by the IASB and as adopted by the EU and that the interim group management report is not prepared, in all material respects, in accordance with the requirements of the WpHG applicable to interim group management reports. A review is limited primarily to making inquiries of the Company's employees and analytical assessments and therefore does not provide the assurance obtainable from an audit of financial statements. Since, in accordance with our engagement, we have not performed an audit of financial statements, we cannot issue an auditor's report.
Based on our review nothing has come to our attention that causes us to believe that the half-year consolidated financial statements are not prepared, in all material respects, in accordance with IFRS applicable to interim financial reporting as issued by the IASB and as adopted by the EU or that the interim group management report is not prepared, in all material respects, in accordance with the provisions of the WpHG applicable to interim group management reports.
Munich, May 5, 2021
Ernst & Young GmbH Wirtschaftsprüfungsgesellschaft
Breitsameter Dr. Gaenslen Wirtschaftsprüferin Wirtschaftsprüfer [German Public Auditor] [German Public Auditor]
C.3 Notes and forward-looking statements
This document contains statements related to our future business and financial performance and future events or developments involving Siemens that may constitute forward-looking statements. These statements may be identified by words such as "expect," "look forward to," "anticipate," "intend," "plan," "believe," "seek," "estimate," "will," "project" or words of similar meaning. We may also make forward-looking statements in other reports, in prospectuses, in presentations, in material delivered to shareholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements are based on the current expectations and certain assumptions of Siemens' management, of which many are beyond Siemens' control. These are subject to a number of risks, uncertainties and factors, including, but not limited to, those described in disclosures, in particular in the chapter Report on expected developments and associated material opportunities and risks of the Annual Report, and in the Half-year Financial Report, which should be read in conjunction with the Annual Report. Should one or more of these risks or uncertainties materialize, events of force majeure, such as pandemics, occur or should underlying expectations including future events occur at a later date or not at all or assumptions prove incorrect, actual results, performance or achievements of Siemens may (negatively or positively) vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Siemens neither intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.
This document includes – in the applicable financial reporting framework not clearly defined – supplemental financial measures that are or may be alternative performance measures (non-GAAP-measures). These supplemental financial measures should not be viewed in isolation or as alternatives to measures of Siemens' net assets and financial positions or results of operations as presented in accordance with the applicable financial reporting framework in its Consolidated Financial Statements. Other companies that report or describe similarly titled alternative performance measures may calculate them differently.
Due to rounding, numbers presented throughout this and other documents may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.
This document is an English language translation of the German document. In case of discrepancies, the German language document is the sole authoritative and universally valid version.
For technical reasons, there may be differences between the accounting records appearing in this document and those published pursuant to legal requirements.
| Address | Siemens AG Werner-von-Siemens-Str. 1 80333 Munich Germany |
|---|---|
| Internet | www.siemens.com |
| Phone | +49 89 636-33443 (Media Relations) +49 89 636-32474 (Investor Relations) |
| Fax | +49 89 636-30085 (Media Relations) +49 89 636-1332474 (Investor Relations) |
| [email protected] [email protected] |
© 2021 by Siemens AG, Berlin and Munich